An update from Celcuity ( ($CELC) ) is now available. On November 17, 2025, Celcuity Inc. announced the submission of its New Drug Application ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug ...

Mr Kanu, who is facing terrorism charges at the Federal High Court in Abuja, recently refused to open his defence on the ...

GSK remains committed to the relaunch of BREXAFEMME, and following its relaunch, SCYNEXIS stands to receive up to $145.5 million in annual net sales milestones as well as royalties, net of payments to ...

Three individuals, Estelle le Grange, Leeroy Scholtz and Ankie-Marie Cilliers, face charges of conspiracy to commit murder, murder and robbery with aggravating circumstances.

Cohesive to aid in enabling a next generation, full-lifecycle asset management solution for the UK Armed Forces ...

A Lagos court adjourns the arraignment of an ex-director in a N20bn fraud case. The defendant is accused of laundering funds from a family inheritance.

Harrow has completed its deal to acquire Melt Pharmaceuticals, according to a company press release. Harrow announced its plan to acquire Melt in September and said it planned to submit a new drug ...

Information relating to Australian military programs was compromised in cyber attacks on defence industry contractors, ...

Explore the complex, decade-long Nnamdi Kanu trial. Learn about the shifting charges, appellate court interventions, and ...

H. Lundbeck A/S (Lundbeck) today announced the acceptance of its new drug application (NDA) for Vyepti® (eptinezumab) by the Ministry of Health, Labor and Welfare (MHLW) in Japan.